Ilex Medical Ltd (ILX.TA)
ILA 6040.0
(-4.22%)
ILA 6040.0
(-4.22%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 77.52 Million ILS | -50.97% |
| 2022 | 158.11 Million ILS | -36.74% |
| 2021 | 249.95 Million ILS | 70.87% |
| 2020 | 146.28 Million ILS | 82.06% |
| 2019 | 80.34 Million ILS | 7.98% |
| 2018 | 74.4 Million ILS | 44.06% |
| 2017 | 51.65 Million ILS | 24.57% |
| 2016 | 41.46 Million ILS | 6.15% |
| 2015 | 39.06 Million ILS | 10.45% |
| 2014 | 35.36 Million ILS | 281.0% |
| 2013 | -19.54 Million ILS | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 19.84 Million ILS | -18.66% |
| 2024 Q2 | 10.89 Million ILS | -45.08% |
| 2023 Q3 | 16.51 Million ILS | -1.92% |
| 2023 Q4 | 24.39 Million ILS | 47.67% |
| 2023 FY | 77.52 Million ILS | -50.97% |
| 2023 Q1 | 19.77 Million ILS | -63.32% |
| 2023 Q2 | 16.84 Million ILS | -14.85% |
| 2022 FY | 158.11 Million ILS | -36.74% |
| 2022 Q4 | 53.92 Million ILS | 103.41% |
| 2022 Q3 | 26.51 Million ILS | 138.85% |
| 2022 Q2 | 11.1 Million ILS | -83.33% |
| 2022 Q1 | 66.57 Million ILS | 29.22% |
| 2021 Q2 | 39.07 Million ILS | -25.58% |
| 2021 Q4 | 51.52 Million ILS | -51.78% |
| 2021 Q3 | 106.85 Million ILS | 173.46% |
| 2021 Q1 | 52.5 Million ILS | 80.52% |
| 2021 FY | 249.95 Million ILS | 70.87% |
| 2020 Q3 | 60.58 Million ILS | 54.63% |
| 2020 Q1 | 17.42 Million ILS | -0.85% |
| 2020 Q2 | 39.18 Million ILS | 124.84% |
| 2020 Q4 | 29.08 Million ILS | -51.99% |
| 2020 FY | 146.28 Million ILS | 82.06% |
| 2019 Q4 | 17.57 Million ILS | -21.48% |
| 2019 FY | 80.34 Million ILS | 7.98% |
| 2019 Q2 | 23.04 Million ILS | 32.85% |
| 2019 Q1 | 17.34 Million ILS | -25.23% |
| 2019 Q3 | 22.38 Million ILS | -2.86% |
| 2018 Q3 | 18.26 Million ILS | -7.33% |
| 2018 Q1 | 13.23 Million ILS | 21.33% |
| 2018 Q2 | 19.7 Million ILS | 48.87% |
| 2018 FY | 74.4 Million ILS | 44.06% |
| 2018 Q4 | 23.19 Million ILS | 27.01% |
| 2017 Q3 | 16.52 Million ILS | 31.02% |
| 2017 Q4 | 10.91 Million ILS | -33.96% |
| 2017 FY | 51.65 Million ILS | 24.57% |
| 2017 Q1 | 11.6 Million ILS | 17.86% |
| 2017 Q2 | 12.61 Million ILS | 8.62% |
| 2016 Q2 | 10.53 Million ILS | 37.92% |
| 2016 Q3 | 13.43 Million ILS | 27.55% |
| 2016 Q1 | 7.63 Million ILS | -39.45% |
| 2016 Q4 | 9.85 Million ILS | -26.71% |
| 2016 FY | 41.46 Million ILS | 6.15% |
| 2015 Q2 | 12.22 Million ILS | -14.29% |
| 2015 Q1 | 14.26 Million ILS | 275.73% |
| 2015 FY | 39.06 Million ILS | 10.45% |
| 2015 Q4 | 12.61 Million ILS | -9.46% |
| 2015 Q3 | 13.93 Million ILS | 13.97% |
| 2014 FY | 35.36 Million ILS | 281.0% |
| 2014 Q4 | -8.11 Million ILS | -133.92% |
| 2014 Q3 | 23.92 Million ILS | 175.49% |
| 2014 Q2 | 8.68 Million ILS | 165.71% |
| 2014 Q1 | 3.26 Million ILS | -70.04% |
| 2013 Q2 | 7.85 Million ILS | -12.31% |
| 2013 Q4 | 10.91 Million ILS | 85.88% |
| 2013 FY | -19.54 Million ILS | 0.0% |
| 2013 Q3 | 5.87 Million ILS | -25.26% |
| 2013 Q1 | 8.95 Million ILS | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|